Project Grant R18HS029458
- This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...
- Federal Grant Award Summary Massachusetts General Hospital (The General Hospital Corporation) received a $2.42M Project Grant from the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865) awarded on September 8, 2025, with a completion date of August 31, 2028. The award funds development of an innovative, multi-modal screening tool for early detection of childbirth-related posttraumatic stress disorder...
- Federal Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded The Leland Stanford Junior University a $1.2M Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and evaluate early interventions for postpartum post-traumatic stress disorder (PTSD). The award, obligated on September 22, 2025, with completion targeted for August 31, 2028, will support a multi-site pilot study assessing the...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to investigate the relationship between postpartum depression (PPD) and microRNA (miRNA) expression patterns in neuron-derived exosomes. The $246,306 grant, awarded on March 17, 2025, will be used by the University of Virginia to leverage existing serum samples from a longitudinal study of pregnant women to examine whether changes in brain-originating...
- This Project Grant award from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) under the CFDA 93.226 Research on Healthcare Costs, Quality and Outcomes program is funding the development and testing of a clinical decision support (CDS) tool to improve iron deficiency screening and management for pregnant individuals at high risk of postpartum hemorrhage (PPH). Specifically, the $118,089 award will support a two-phase project at Massachusetts...
- New York University School of Medicine received a $156,080 Project Grant award effective January 1, 2026, through August 31, 2028, from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The research investigates the neurobiological mechanisms by which postpartum sickness impacts maternal caregiving behaviors, with particular focus on how inflammatory stress disrupts neuropeptidergic...
- Federal Project Grant Award Summary Dartmouth-Hitchcock Clinic received a $350,000 Project Grant award from the National Institute of Mental Health (NIMH) effective August 1, 2025, under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports a randomized controlled trial evaluating the effectiveness of Resilience Enhancement Skills Training (REST), a video-based family therapy intervention, compared to standard-of-care video-based problem-solving individual...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded Tulane University $124,038 on August 11, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and evaluate a digital mental health intervention (DMHI) for pregnant individuals with a history of childhood neglect. The project, which extends through July 31, 2027, addresses a critical public health gap by adapting an existing...
- Federal Project Grant Award Summary Dartmouth-Hitchcock Clinic received a $658,761 Project Grant award dated August 25, 2025, from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports a research initiative titled "Deep Learning to Improve Interpretation of Intrapartum Fetal Monitoring" and will extend through April 30, 2030. The project develops and validates a...
- Federal Grant Award Summary Boston Children's Hospital received a $178,000 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective May 9, 2025, through April 30, 2027. The award funds research investigating the effects of maternal genetic risk factors for Polycystic Ovary Syndrome (PCOS) on birth and childhood outcomes in offspring. The research leverages...
PERINATAL MOOD AND ANXIETY LEARNING LABORATORY IN A FREESTANDING CHILDREN'S HOSPITAL - PROJECT SUMMARY/ABSTRACT POSTPARTUM DEPRESSION (PPD) IS THE MOST COMMON MEDICAL COMPLICATION OF CHILDBIRTH THAT REMAINS UNDERRECOGNIZED AND UNDERTREATED. CHILDREN'S HOSPITALS ARE IDEAL SITES FOR POSTPARTUM MENTAL HEALTHCARE BECAUSE MOTHERS IN THE NEONATAL INTENSIVE CARE UNIT (NICU) ARE AT HIGH RISK AND THOSE SEEKING CARE IN THE PEDIATRIC EMERGENCY DEPARTMENT (PED) OFTEN MISS ROUTINE OFFICE VISITS WITH A PEDIATRICIAN OR OBSTETRICIAN. THE FIRST STEP TO REDUCING THE NEGATIVE CONSEQUENCES ASSOCIATED WITH UNTREATED PPD IS TIMELY SCREENING AND SELF- AWARENESS OF DEPRESSIVE SYMPTOMS. HOWEVER, SCREENING NICU MOTHERS AND IN THE PED IS UNCOMMON, EXPENSIVE, PERSONNEL-HEAVY, AND TIME-CONSUMING. THE SECOND STEP IS REFERRAL AND TREATMENT WHICH IS MULTIFACETED AND REQUIRES PARENTS TO NAVIGATE DIFFERENT PARTS OF THE HEALTHCARE SYSTEM, A VAST ENDEAVOR FOR A DEPRESSED INDIVIDUAL. REDESIGN OF HEALTHCARE SYSTEMS TO PERMIT SEAMLESS SCREENING, REFERRAL, AND TREATMENT OF MOTHERS WITH PPD CREATING AN EFFICIENT "ONE-STOP-SHOP SOLUTION" IS URGENTLY NEEDED. OUR LONG-TERM GOAL IS TO PROVIDE SAFE, COMPREHENSIVE, POINT-OF-CARE ACCESS TO MENTAL HEALTH SERVICES FOR PARENTS OF INFANTS TREATED IN CHILDREN'S HOSPITALS. THE OVERALL OBJECTIVE IS TO CREATE A PERINATAL MOOD AND ANXIETY DISORDER (PMAD) LEARNING LABORATORY USING A FIVE-PHASE SYSTEMS ENGINEERING APPROACH THAT DEVELOPS NEW SOLUTIONS FOR CLINICAL RECOGNITION AND THERAPY FOR PPD. OUR SPECIFIC AIMS ARE 1. TO OPTIMIZE SCREENING, REFERRAL, AND TREATMENT FOR POSTPARTUM DEPRESSION IN THE NICU AND PED USING SYSTEM DYNAMICS GROUP MODEL BUILDING TECHNIQUES. WE WILL ANALYZE THE CURRENT WORKFLOW, IDENTIFY BARRIERS, ELICIT SYSTEM REQUIREMENTS FROM STAKEHOLDERS, MAP THE SYSTEM, AND DEVELOP A SYSTEM DYNAMICS SIMULATION MODEL TO TEST SOLUTIONS IN A VIRTUAL ENVIRONMENT. 2. TO DESIGN A NOVEL SOFTWARE DASHBOARD FOR REAL-TIME TRACKING OF ELIGIBLE MOTHERS WITH ITS ACCOMPANYING PARENT-FACING APP AND DEVELOP A PREDICTIVE MODEL TO IDENTIFY AT-RISK MOTHERS. WE WILL THEN DEVELOP A MEASUREMENT SYSTEM TO MONITOR KEY PERFORMANCE INDICATORS. 3. TO IMPLEMENT NEW SOLUTIONS, MONITOR, AND EVALUATE THE SYSTEM FOR UNINTENDED CONSEQUENCES BEFORE AND AFTER IMPLEMENTATION. A DIFFERENCE IN DIFFERENCE, AND COST-BENEFIT ANALYSIS WILL BE CONDUCTED TO EVALUATE THE CHANGES. OUR PMAD LEARNING LAB IS INNOVATIVE BECAUSE IT IS A SIGNIFICANT DEPARTURE FROM TRADITIONAL TECHNIQUES USING NOVEL APPROACHES AND NEW TECHNOLOGY TO ASSIST IN THE RECOGNITION AND TREATMENT OF PPD ON A LARGE SCALE IN REAL-WORLD SETTINGS IN THE NICU AND PED OF A FREE- STANDING CHILDREN'S HOSPITAL. THIS IS SIGNIFICANT BECAUSE IF SUCCESSFUL IT WILL BE GENERALIZABLE TO THE TREATMENT OF OTHER MENTAL HEALTH DISORDERS THAT AFFECT POSTPARTUM PARENTS AND WILL CONTRIBUTE TO IMPROVEMENT IN SHORT- AND LONG-TERM HEALTH OUTCOMES OF PARENTS AND INFANTS WHO ARE AT A HIGHER RISK THAN THE GENERAL MATERNAL POPULATION.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $445.1k | 9/10/25 | ||
| Not listed | $0 | 7/29/24 | ||
| Not listed | $458.8k | 7/29/24 | ||
| Not listed | $473.4k | 9/15/23 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
3000818301S | Virginia Polytechnic Institute & State University | Project Grant R18HS029458 | $514.9k | 4/16/26 | |
3000818302S | Medstar Health Research Institute Inc. | Project Grant R18HS029458 | $70.0k | 3/17/26 |